BERINERT

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug BERINERT contains one active pharmaceutical ingredient (API):

1 C1-inhibitor UNII 6KIC4BB60G - HUMAN C1-ESTERASE INHIBITOR

C1 inhibitor is a single chain glycoprotein found in plasma and a member of the serine protease inhibitor, or serpin, superfamily of proteins. C1 inhibitor inhibits the complement system by binding C1r and C1s and is the most important inhibitor of contact activation, regulating the contact system and the intrinsic coagulation pathway by binding to and inactivating kallikrein and factor XIIa. Read about C1-inhibitor

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B06AC01	C1-inhibitor, plasma derived	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AC Drugs used in hereditary angioedema
Discover more medicines within B06AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502614070006902, 502617100007902, 502621040010703, 502621040010803
Country: CA	Health Products and Food Branch	Identifier(s): 02352575, 02436078
Country: EE	Ravimiamet	Identifier(s): 1351392, 1836503, 1836514, 1836525, 1836536, 1853816, 1853827, 1853838, 1853849
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 70695, 79703, 82884, 82885
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 168119, 451428
Country: FR	Base de données publique des médicaments	Identifier(s): 61846118
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 109220, 309211
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-170893029, HR-H-323302356, HR-H-828344348, HR-H-917245852
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6677
Country: JP	医薬品医療機器総合機構	Identifier(s): 6343426D1023, 6343426F1032
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1090621
Country: MT	Medicines Authority	Identifier(s): MA665/00501, MA665/00502, MA665/00503, MA665/00504
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100212265, 100338807, 100383699, 100383707
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W58531001, W61669001, W65555001, W65555002, W65555003, W65559001, W65559002, W65559003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681624980378